Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
-

Drugs

  • Share Share this page
-

Pharmacogenomics Education Initiatives

The FDA has organized various workshops (see Upcoming Events for future workshops and Publications for proceedings from past workshops) with PhRMA, BIO and other organizations designed to both educate and provide feedback on pharmacogenomics.  In addition, a number of articles have been published, encouraging a broad public education in pharmacogenomics and personalized medicine.

A new lecture series entitled “Pharmacogenomics from the Ground Up” designed for scientists with diverse academic and professional backgrounds is being held regularly and has been integrated into the ongoing education for reviewers within CDER.  So far, the course is set up in three sessions

Additional continuing education lecture series are planned to include speakers from the diagnostic and pharmaceutical industries responsible for the development of molecular diagnostics and of drugs for which pharmacogenomic data made a difference in therapeutic efficacy or safety.

Please contact us via email: fdagenomics@fda.hhs.gov for the presentations and more information on pharmacogenomics.

2009
  • "Human Leukocyte antigens (HLAs) and adverse drug reactions (ADRs)" Shashi Amur, Ph.D, CDER April 2009, Walter Reed Army Institute of Research (WRAIR), MD presentations
2008
  • "Pharmacogenomics Information in Drug Labels and Re-labeling efforts at FDA" Shashi Amur, Ph.D. and Padmaja Mummaneni, Ph.D., CDER, December 2008 Temple University, PA presentation
2007
2005
    
-
-
-
-
-